This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fabian, T. J. Articles by Pollock, B. G. Search for Related Content PubMed PubMed Citation Articles by Fabian, T. J. Articles by Pollock, B. G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB VASOPRESSIN Social Bookmarking                         What's this?

Paroxetine-Induced Hyponatremia in the Elderly due to the Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH)

Intervention Research Center for Late Life Mood Disorders, University of Pittsburge

Janet A. Amico, MD

Intervention Research Center for Late Life Mood Disorders, University of Pittsburge

Patricia D. Kroboth, PhD

Intervention Research Center for Late Life Mood Disorders, University of Pittsburge

Benoit H. Mulsant, MD

Intervention Research Center for Late Life Mood Disorders, University of Pittsburge

Charles F. Reynolds, III, MD

Intervention Research Center for Late Life Mood Disorders, University of Pittsburge

Bruce G. Pollock, MD, PhD

Intervention Research Center for Late Life Mood Disorders, University of Pittsburge

This study investigated the development of hyponatremia and its underlying mechanism in elderly patients prescribed paroxetine. Patients were 15 men and women (mean age, 75.7 ± 5.3 years) who were participants in a treatment study of late-life depression and who were without medical illness or other medications known to cause hyponatremia or alter antidiuretic hormone (ADH) secretion. Blood samples for measurement of plasma sodium, ADH, blood urea nitrogen (BUN), creatinine, glucose, and osmolality were determined prior to initiation of paroxetine (week 0) and at 2, 4, 6, and 12 weeks of treatment with paroxetine. Hyponatremia (serum sodium < 135 mEq/L) was identified in 6 of 15 patients after 2 weeks of treatment with paroxetine. Despite low plasma osmolality, ADH levels were not suppressed appropriately. Data suggest hyponatremia is a common adverse event in elderly patients prescribed paroxetine and implicates inappropriate secretion of ADH as the potential mechanism. (J Geriatr Psychiatry Neurol 2003; 16:160-164).

Key Words: paroxetine • hyponatremia • SIADH • elderly • SSRI

Journal of Geriatric Psychiatry and Neurology, Vol. 16, No. 3, 160-164 (2003)
DOI: 10.1177/0891988703255689


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?